Clinical trials
Biologics clinical trials
Below are recruiting biologics clinical trials, each written for real people, not researchers. We’re tracking 622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07330934RecruitingPhase 2
Study of IBI356 for moderate to severe eczema
This study tests a new medication called IBI356 for people with moderate to severe eczema that hasn't improved with standard creams. The goal is to see if this medicine can safely reduce the redness, itching, and rash.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07327229RecruitingPhase 1/Phase 2
Study of ATG-022 plus pembrolizumab for stomach or GEJ cancer
This trial tests a new drug combo (ATG-022 plus pembrolizumab, with or without chemo) for people with advanced stomach or gastroesophageal junction cancer that has a specific protein (CLDN 18.2) and is HER2-negative and PD-L1-positive. It may be an option if you have not had certain prior treatments.
Hefei, AnhuiAges 18 years+ - NCT07327307Recruiting
Study of SYN023 for children exposed to rabies
This study looks at how well the rabies treatment SYN023 works in children under 18 who have had a high-risk (Category III) animal bite. It tests a combination of medications given right after the bite to prevent rabies.
Beijing, Beijing MunicipalityAges birth–17 years - NCT07334106Recruiting
Emotional Well-Being and Healthy Aging
This study looks at how emotional well-being affects healthy aging. Participants will answer online questions and visit a lab near Chicago.
Chicago, IllinoisAges 40–70 - NCT07332260RecruitingPhase 1
Fecal transplant for Alzheimer's disease
This study tests whether a fecal transplant (transferring healthy bacteria from a donor's stool into your colon) can improve memory and thinking in people with mild to moderate Alzheimer's. You would receive the transplant via colonoscopy and have follow-up brain scans.
Tromsø, TromsAges 18 years+ - NCT03559569Recruiting
Study blood changes in people with circulatory shock
This study looks at how blood vessel and white blood cell aging changes during circulatory shock. Your participation may help doctors better understand what’s happening in the body during shock.
StrasbourgAges 18 years+ - NCT07316361Enrolling by invitationEarly Phase 1
Personalized vaccine for high-risk endometrial cancer
This trial tests a personalized vaccine made from your tumor's unique proteins to help your immune system fight high-risk or advanced endometrial cancer. It is given along with your regular cancer treatments.
Thessaloniki, ThessalonikiAges Any age - NCT07322406Recruiting
Kaempferol absorption and processing in healthy adults
This study is testing how your body absorbs and processes kaempferol, a natural compound found in fruits and vegetables. It involves taking kaempferol and having blood and urine tests.
New York, New YorkAges 18–70 - NCT05793034Recruiting
Study factors that predict survival after aggressive meningioma surgery
This study looks at people who had surgery for more aggressive meningiomas (grade 2 or 3) and tries to learn what factors relate to survival. The results may help doctors better predict outcomes for future patients.
RomeAges 18 years+ - NCT05941234Recruiting
Studying stem cells and blood patterns in glioblastoma
This study analyzes tissue and health-related biological data from people with glioblastoma to learn what’s happening in the tumor. The results may help improve future ways to understand and treat glioblastoma using advanced computer analysis.
RomeAges 18 years+ - NCT07312474Recruiting
Study of Anaplasmosis Cases in Alsace
This study looks at people in Alsace, France, who have been diagnosed with anaplasmosis (a tick-borne infection). It aims to understand the disease's patterns and symptoms.
StrasbourgAges 18 years+ - NCT07312864RecruitingPhase 1/Phase 2
New bioartificial liver for liver failure and small-for-size syndrome
This study tests a new bioartificial liver made from special cells to support people with severe liver problems, including liver failure or when the liver is too small after surgery. It aims to see if it is safe and can help the liver recover.
BeijingAges Any age - NCT07302256RecruitingPhase 1
Flu vaccine trial for adults 60 and older
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
Wuhan, HubeiAges 60 years+ - NCT07303296RecruitingPhase 2
Gene therapy study for vision loss from LHON
This trial tests a gene therapy called GS010 given as an injection into the eye for people with vision loss from LHON. It aims to see if it can help improve vision in both eyes.
ParisAges 15 years+ - NCT07299448Recruiting
Parkinson's and swallowing: what drives difficulty?
This study looks at why some people with Parkinson's have trouble swallowing (dysphagia) and how the brain adapts. It aims to understand the condition better, which could lead to better treatments.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07291128Recruiting
VOJTA therapy for children with ataxic cerebral palsy
This trial tests a special movement therapy called VOJTA technique to help improve balance and coordination in children with ataxic cerebral palsy. It may offer a gentle way to help your child move better.
Lahore, Punjab ProvinceAges 2–6 - NCT07292805Recruiting
Bronchial thermoplasty for severe asthma
This study tests a procedure called bronchial thermoplasty for adults with severe asthma that is not controlled with standard treatments. It aims to see if this can help reduce asthma attacks in people who have already tried or cannot use biologic therapies.
AmsterdamAges 18 years+ - NCT07292870Recruiting
Biological treatments for deep gum bone defects
This trial tests whether biological agents can help heal deep gum bone defects that remain after standard non-surgical cleaning. It may be an option for people who still have deep pockets around their teeth and need a minimally invasive surgical procedure.
Leuven, Vlaams BrabantAges 18 years+ - NCT07296107Recruiting
IVF and pregnancy study at Columbia
This study looks at how IVF pregnancies affect mothers and babies, separate from genetic factors. If you are pregnant at 18-28 weeks and receiving care at Columbia University Medical Center, you and your baby may be eligible.
New York, New YorkAges 18–50 - NCT06882148Recruiting
How long do eczema patients stay on targeted therapies?
This study looks at how long people with moderate to severe eczema stay on newer targeted medicines (biologics or pills). By reviewing medical records, researchers hope to learn which treatments work best over time and how they are used in real life.
RomeAges 18 years+ - NCT05924074Recruiting
Study of ferroptosis therapy in blood disorders with SF3B1 mutation
This study looks at ferroptosis (a type of cell stress that can affect blood-forming cells) in people with certain blood disorders linked to an SF3B1 gene change. It may help researchers understand whether targeting this pathway could improve outcomes.
PessacAges 18 years+ - NCT07284407Recruiting
Learning about pain and touch training for long-term back pain
This study tests two types of therapy for ongoing low back pain: learning about how pain works (pain education) and training your sense of touch (sensory discrimination). The goal is to help your brain process pain better and reduce discomfort.
LahoreAges 19–44 - NCT07285187Recruiting
Vein congestion and confusion after heart surgery trial
This trial looks at how blood backing up in veins after heart surgery might relate to delirium (sudden confusion). It uses a special ultrasound to check vein blood flow and then watches for confusion afterward.
Yangzhou, JiangsuAges 18 years+ - NCT07282938Recruiting
Robot hand and electrical stimulation for hand function after stroke
This test combines a soft robotic hand and electrical stimulation to help improve hand movement in people recovering from a stroke. It may benefit stroke survivors who have some ability to extend their fingers and are in the early months of recovery.
Lahore, Punjab ProvinceAges 45–65
Hear when a new Biologics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biologics?
- Yes. Clin2 currently lists 622 recruiting biologics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biologics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biologics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.